This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations of Narayan Vanankaval
Introduction
Narayan Vanankaval is an accomplished inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of phosphodiesterase-4 inhibitors. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Narayan holds a patent for an invention titled "Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide." This invention is directed towards alternative forms of the phosphodiesterase-4 inhibitor, which has a specific structural formula. His patent represents a significant advancement in the field, with potential benefits for patients requiring targeted therapies.
Career Highlights
Narayan is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck allows him to collaborate with other talented professionals in the industry. His dedication to research and development has positioned him as a valuable asset within the organization.
Collaborations
Some of Narayan's notable coworkers include Hongshi Yu and Sophie-Dorothee Clas. Their collaborative efforts contribute to the innovative environment at Merck, fostering advancements in pharmaceutical research.
Conclusion
Narayan Vanankaval's contributions to the field of pharmaceuticals through his patent and work at Merck Sharp & Dohme Corp. highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in medical treatments.